EBICO promotes the transformation of environmental protection in the pharmaceutical industry
author： 2019-10-12
In recent years, "low nitrogen transformation" has become a high frequency word in the green transformation process of heating, food, electricity, medicine and other industries, and its influence cannot be ignored.So what is "low nitrogen modification"?
With the completion of the transformation of thermal power units, the amount of coal burning is gradually decreasing, and the consumption of natural gas will increase accordingly.It should be noted that the combustion of natural gas is likely to be the main source of nitrogen oxide pollution, which can be avoided as much as possible through the transformation of low nitrogen technologies, such as low nitrogen combustion technologies.
Recently, nanjing hailing pharmaceutical co., ltd. and oubao cooperated to complete the transformation of furnace production process, becoming the first private enterprise in qixia district of nanjing city to complete the task of "low nitrogen transformation".Eubao provides one set of ES600GE and one set of ES600GGE burners respectively to hailing pharmaceutical co., LTD., which are suitable for 8-ton steam boilers.
In the process of boiler "low nitrogen transformation", burner plays a crucial role.The comprehensive performance of burner will directly affect the discharge effect of nox and other pollutants.In August, nanjing issued the "anti-air pollution measures in the second half of 2019", which made the "low-nitrogen transformation of boilers" one of the important measures to improve air quality.Hailing pharmaceutical co., LTD responded positively and chose oubao burner after in-depth market research.
Relying on the advanced Italian production technology, EBICO burner has entered the Chinese market for more than 30 years. It has cooperated with related enterprises in the pharmaceutical industry to carry out boiler transformation projects for many times, such as Shanghai junshi biopharmaceutical, xuzhou fushan medical, shandong fusaichun biochemical and other well-known domestic pharmaceutical enterprises, which are our long-term partners.
By the city, district ecological environment department on-site verification, after the transformation of the average NOx emissions from 84 mg/m3 to 28 mg/m3, far less than the document requirements of 50 mg/m3, converted each year can reduce 1.72 tons of pollutants emissions, a year-on-year decline of 66.67%.
The ES600GE series burner involved in this project is one of the core products newly launched by euroassurance, which can be applied to natural gas, light oil and other fuels according to customer needs.This burner adopts multi-channel air distribution/multi-channel air distribution, central premix and other European patented technologies, which can reduce the emission of NOX and CO to extremely low, and effectively reduce the working noise by about 30%, which is very suitable for the market demand under the background of "low-nitrogen transformation" policy.
"Low nitrogen transformation" is a long way to go. EBICO is willing to work with the pharmaceutical industry to pay equal attention to social and economic benefits and shoulder its due corporate responsibilities.